Shanghai, China · Founded 2014 · Privately Held (backing)
Operator of a biopharma platform intended to address critical unmet needs in the Asia Pacific region. Nuance Pharma is based in Shanghai, China and was founded in 2014. Its last reported valuation was $623 million in Jul 2025. It has raised $306 million.
Last reported valuation
$623.1M
Oct 2026
Priced at
—
Total raised
$305.8M
Last round
—
Team — not yet on record
No current team members for Nuance Pharma are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Nuance Pharma with a free account
·Watch Nuance Pharma: the Monday email on marks, rounds and moves
